阿替佐利单抗和贝伐单抗与索拉非尼治疗肝癌的成本-效果分析：系统评价

{"title":"阿替佐利单抗和贝伐单抗与索拉非尼治疗肝癌的成本-效果分析：系统评价","authors":"B. Balkhi, Abdulaziz Alotaibi, Faris A. Alotaibi","doi":"10.5530/097515050547","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17623,"journal":{"name":"Journal of Young Pharmacists","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost-Effectiveness Analysis of Atezolizumab and Bevacizumab versus Sorafenib in the Treatment of Hepatocellular Carcinoma: A Systematic Review\",\"authors\":\"B. Balkhi, Abdulaziz Alotaibi, Faris A. Alotaibi\",\"doi\":\"10.5530/097515050547\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17623,\"journal\":{\"name\":\"Journal of Young Pharmacists\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Young Pharmacists\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5530/097515050547\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Young Pharmacists","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/097515050547","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}